Coating Service for microplates, beads, membranes, biochips etc.

  • Streptavidin coating
  • Antibody coating
  • Immune conjugate coating 

Coated Microplates

  • Streptavidin-coated 8-well strip plate, C well, clear Polystyrene
  • Streptavidin-coated 8-well strip plate, C well, black Polystyrene
  • Polystreptavidin-coated 8-well strip plate, C well, clear Polystyrene
  • Polystreptavidin-coated 8-well strip plate, C well, black Polystyrene
  • Polystreptavidin-coated 96-well plate, V well, natural Polypropylene
  • Polystreptavidin-coated 384-well plate, V well, natural Polypropylene
  • Antibody (Goat anti-Rabbit)-coated 8-well strip plate, C well, clear Polystyrene
  • Antibody (Goat anti-Rabbit)-coated 8-well strip plate, C well, black Polystyrene
  • Protein G-coated 8-well strip plate, C well, clear Polystyrene
  • Protein G-coated 8-well strip plate, C well, black Polystyrene
  • Customized Microplates

BioTeZ GmbH

Die BioTeZ Berlin-Buch GmbH ist ein Biotechnologie-Unternehmen und wurde 1992 gegründet. BioTeZ ist Partner der Forschung, der Pharmaindustrie und der Labordiagnostik.

  • Biodiagnostika
  • Oligonukleotide
  • Markierte Biomoleküle

Kontakt

BioTeZ Berlin Buch GmbH
Robert-Rössle-Strasse 10, Haus D 72
13125 Berlin - Germany

Tel: +49 30-9489-2130
Fax: +49 30-9494-509
E-Mail: info@biotez.de
www.biotez.de

Events

MedicaMeet BioTeZ at MEDICA, 12-15 Nov. 2018, Düsseldorf, hall 3, booth G54. 


10th Potsdam Days on Bioanalysis (1./2. November 2018), Potsdam; 
Dr. Janko Brand will give insights in the development projects: recoveryELISA Alirocumab, Evolocumab and PCSK9


SWISS BIOTECH DAY 2018 (3 May 2018, Basel)   Swiss_Biotech_Day
Get Information about diagnostics and biotechnological services we offer: Therapeutic Drug Monitoring, Mycotoxin and Vitamin Analysis, Individual Conjugates, ELISA Development, Oligonucleotides, Human Proteases Research, Streptavidin Coatings, Immobilization Technologies; BioTeZ will summarize outcomes of therapeutic drug monitoring studies with Omalizumab/IgE, Adalimumab/TNF and provide insights into Alirocumab, Evolocumab/PCSK9 recoveryELISA Projects.


Deutsche Biotechnologietage We present at Deutsche Biotechnologietage 18-19 April 2018